These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2841789)

  • 1. Induction of antibodies to glycoprotein I in pigs exposed to different doses of a mildly virulent strain of Aujeszky's disease virus.
    van Oirschot JT
    Vet Rec; 1988 Jun; 122(25):599-603. PubMed ID: 2841789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay.
    van Oirschot JT; Rziha HJ; Moonen PJ; Pol JM; van Zaane D
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1179-82. PubMed ID: 3011974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel concept for the control of Aujeszky's disease: experiences in two vaccinated pig herds.
    van Oirschot JT; Wijsmuller JM; de Waal CA; van Lith PM
    Vet Rec; 1990 Feb; 126(7):159-63. PubMed ID: 2155499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an ELISA for detection of antibodies to glycoprotein I of Aujeszky's disease virus: a method for the serological differentiation between infected and vaccinated pigs.
    van Oirschot JT; Houwers DJ; Rziha HJ; Moonen PJ
    J Virol Methods; 1988 Dec; 22(2-3):191-206. PubMed ID: 2851599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs.
    Kit M; Kit S
    Vet Microbiol; 1991 Jul; 28(2):141-55. PubMed ID: 1651582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
    Van Oirschot JT
    Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63.
    van der Leek ML; Feller JA; Sorensen G; Isaacson W; Adams CL; Borde DJ; Pfeiffer N; Tran T; Moyer RW; Gibbs EP
    Vet Rec; 1994 Jan; 134(1):13-8. PubMed ID: 8128561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus.
    van Oirschot JT; Daus F; Kimman TG; van Zaane D
    Am J Vet Res; 1991 Nov; 52(11):1788-93. PubMed ID: 1664670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of experimental infection with pseudorabies (Aujeszky's disease) virus on pigs with maternal immunity from vaccinated sows.
    Andries K; Pensaert MB; Vandeputte J
    Am J Vet Res; 1978 Aug; 39(8):1282-5. PubMed ID: 211882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local humoral and cellular responses in Aujeszky's disease virus infection in pigs.
    Martin S; Wardley RC
    Res Vet Sci; 1987 Mar; 42(2):170-4. PubMed ID: 3035662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction between Aujeszky's disease virus-infected and vaccinated pigs by hemagglutination-inhibition test.
    Shibata I; Uruno K; Samegai Y; Inaba Y
    J Vet Med Sci; 1993 Oct; 55(5):859-61. PubMed ID: 8286546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A method for distinguishing infected from vaccinated pigs as a basis for the control of Aujeszky's disease].
    van Oirschot JT
    Tijdschr Diergeneeskd; 1988 Jan; 113(1):19-27. PubMed ID: 2829384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies.
    Kimman TG
    Vaccine; 1992; 10(6):363-5. PubMed ID: 1317982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine.
    Hopp W; Jungblut R
    Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines.
    Pensaert MB; De Smet K; De Waele K
    Vet Microbiol; 1990 Apr; 22(2-3):107-17. PubMed ID: 2162094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal vaccination of pigs against Aujeszky's disease: protective immunity at 2 weeks, 2 months and 4 months after vaccination in pigs with maternal antibodies.
    van Oirschot JT
    Vet Microbiol; 1991 Apr; 27(2):103-13. PubMed ID: 1648282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the protective efficacy of Aujeszky's disease (pseudorabies) virus glycoproteins obtained from different sources.
    Puentes E; Eiras A; Cancio E; Nores MV; Aguilera A; Seoane R; Regueiro BJ
    Vet Microbiol; 1993 May; 35(1-2):45-59. PubMed ID: 8395745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines.
    Vannier P; Hutet E; Bourgueil E; Cariolet R
    Vet Microbiol; 1991 Nov; 29(3-4):213-23. PubMed ID: 1663287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an ELISA to differentiate between animals either vaccinated with or infected by Aujeszky's disease virus.
    Eloit M; Fargeaud D; Vannier P; Toma B
    Vet Rec; 1989 Jan; 124(4):91-4. PubMed ID: 2538951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.